ALGN

AlignD

Nasdaq / Health Care Equipment & Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$205.00

+23.0% vs current

Most likely

Base case

45%

Probability

Target price

$174.00

+4.4% vs current

B-

Bear case

30%

Probability

Target price

$150.00

-10.0% vs current

AI sentiment snapshot

Latest data as of 2026-04-29

AI commentary

This is a monitoring-style setup, not a confirmed post-earnings thesis update. The recent news flow was moderate but mostly company-driven, and the key earnings catalyst had not yet hit the tape as of 2026-04-29 18:58 UTC; at that time ALGN traded at $178.12 versus the 2026-04-28 anchor close of $177.28, a minimal pre-release move. Because trustworthy analyst revision data and the company earnings release were not yet available, near-term sentiment should be treated as tentative rather than constructive.

RankAlpha Sentiment Codex - 2026-04-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-29eventQ1 2026 earnings and guidance check arrive after market close on April 29Medium impact

Align said on April 1, 2026 that it would report Q1 2026 results after the close on April 29, 2026, and its February 4 outlook called for Q1 revenue of $1.01B-$1.03B, mid-single-digit Clear Aligner volume growth, sequential ASP improvement, and roughly 19.5% non-GAAP operating margin; as of 2026-04-29 18:58 UTC, the release was not yet available, so the next catalyst is the actual print versus that setup [#PR-2026-04-01] [#PR-2026-02-04].

2026-12-31catalyst2026 margin and growth plan still needs proof through quarterly executionHigh impact

Management's fiscal 2026 outlook calls for 3%-4% revenue growth, mid-single-digit Clear Aligner volume growth, and about 23.7% non-GAAP operating margin after a Q4 2025 finish that beat its own outlook; if Q1 and later quarters confirm those targets, the stock can re-rate from a low-confidence monitoring setup toward a cleaner recovery thesis [#PR-2026-02-04].

2026-12-31catalystDigital dentistry platform adoption remains a real but execution-sensitive supportHigh impact

Align exited 2025 with over 121 thousand active iTero scanner units, over 70 thousand exocad licenses, over 295 thousand active Invisalign-trained doctors, and a stated 600 million global malocclusion opportunity; continued iTero Lumina upgrades and doctor workflow adoption can support Systems and Services mix and future case conversion, but the benefit depends on sustained doctor and consumer demand [#PR-2026-02-04] [#10-K-2026-02-27].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-04-29 • Updated nightlySource: Internal modelMethodology